Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Janssen Ortho is an active Johnson & Johnson-controlled pharmaceutical manufacturing and operating entity associated with the Janssen/Johnson & Johnson Innovative Medicine organization. The name appears to refer primarily to a legal manufacturing company, Janssen Ortho LLC, with operations tied to Puerto Rico, rather than a standalone R&D biotech with its own independently disclosed pipeline. Public sources indicate it manufactures pharmaceutical products and has been listed as a finished-product manufacturing site for Johnson & Johnson medicines such as Xarelto. In commercial practice, the broader Janssen brand has been renamed Johnson & Johnson Innovative Medicine, which markets medicines across oncology, immunology, neuroscience, cardiopulmonary disease, and related areas. For analyst purposes, Janssen Ortho is best understood as a subsidiary legal/manufacturing entity within Johnson & Johnson's pharmaceutical network rather than an independent public biopharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Janssen Ortho.